As our previous study indicates a possible role of EZH2 in diabetes-associated inflammatory switch of endothelial cells (Thakar et al., 2021), EZH2 indeed is also reported to be an important modulator of EndMT during both development and disease. This evidence concerns the gene EZH2 and diabetes mellitus.